Total Payments
$5,365
2024 Payments
$897.37
Companies
40
Transactions
281
Medicare Patients
1,669
Medicare Billing
$254,843
Payment Breakdown by Category
Food & Beverage$5,203 (97.0%)
Travel$141.57 (2.6%)
Education$20.72 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,203 | 278 | 97.0% |
| Travel and Lodging | $141.57 | 1 | 2.6% |
| Education | $20.72 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $515.35 | 26 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $393.18 | 22 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $344.58 | 20 | $0 (2024) |
| Biogen, Inc. | $316.45 | 18 | $0 (2023) |
| ABBVIE INC. | $291.77 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $281.95 | 15 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $277.27 | 17 | $0 (2022) |
| SK Life Science, Inc. | $246.59 | 11 | $0 (2024) |
| Grifols USA, LLC | $230.39 | 14 | $0 (2024) |
| LivaNova USA, Inc. | $214.32 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $897.37 | 44 | PFIZER INC. ($165.39) |
| 2023 | $918.25 | 44 | Abbott Laboratories ($115.58) |
| 2022 | $806.40 | 43 | ACADIA Pharmaceuticals Inc ($134.25) |
| 2021 | $706.12 | 35 | UCB, Inc. ($99.38) |
| 2020 | $448.27 | 24 | ACADIA Pharmaceuticals Inc ($59.18) |
| 2019 | $440.66 | 26 | UCB, Inc. ($67.27) |
| 2018 | $509.25 | 34 | Biogen, Inc. ($96.91) |
| 2017 | $638.95 | 31 | LivaNova USA, Inc. ($166.57) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PAIN | ||||||
| 12/04/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.12 | General |
| 11/20/2024 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/02/2024 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $7.04 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Immunology and Neurology | ||||||
| 09/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $38.27 | General |
| Category: Neuropsychiatry | ||||||
| 09/12/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Neuroscience | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: PAIN | ||||||
| 08/14/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Neuroscience | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.87 | General |
| 07/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: PAIN | ||||||
| 07/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: PAIN | ||||||
| 07/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 06/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: PAIN | ||||||
| 06/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/31/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Neurology | ||||||
| 05/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: PAIN | ||||||
| 05/15/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 480 | 678 | $137,467 | $65,661 |
| 2022 | 9 | 401 | 554 | $112,857 | $59,728 |
| 2021 | 8 | 376 | 564 | $113,237 | $64,364 |
| 2020 | 10 | 412 | 619 | $127,455 | $65,090 |
Total Patients
1,669
Total Services
2,415
Medicare Billing
$254,843
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 256 | $51,142 | $24,539 | 48.0% |
| 96125 | Test to assess the ability to complete specific functional tasks applicable to environment | Office | 2023 | 63 | 99 | $14,850 | $7,882 | 53.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 41 | 93 | $13,950 | $7,334 | 52.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 36 | 36 | $12,600 | $6,803 | 54.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 53 | $15,900 | $6,712 | 42.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 14 | 14 | $8,400 | $5,022 | 59.8% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 14 | 14 | $8,400 | $3,118 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 23 | $8,050 | $2,748 | 34.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 77 | 77 | $3,850 | $1,436 | 37.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 13 | $325.00 | $67.08 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 224 | $36,550 | $20,999 | 57.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 26 | 26 | $15,600 | $9,611 | 61.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $14,450 | $6,684 | 46.3% |
| 96125 | Test to assess the ability to complete specific functional tasks applicable to environment | Office | 2022 | 57 | 75 | $11,207 | $6,278 | 56.0% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2022 | 26 | 26 | $15,600 | $5,638 | 36.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 26 | 66 | $9,900 | $5,519 | 55.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 20 | 20 | $7,000 | $4,192 | 59.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 36 | 36 | $1,900 | $677.52 | 35.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 26 | 26 | $650.00 | $130.95 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 136 | 243 | $36,450 | $22,695 | 62.3% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 24 | 24 | $14,400 | $9,148 | 63.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 37 | 96 | $14,400 | $8,238 | 57.2% |
| 96125 | Standardized thought processing testing, interpretation, and report per hour | Office | 2021 | 57 | 79 | $11,787 | $6,762 | 57.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $11,750 | $6,371 | 54.2% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 27 | 27 | $9,450 | $5,925 | 62.7% |
About Dr. Sadia Yasser, M.D
Dr. Sadia Yasser, M.D is a Neurology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558453522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sadia Yasser, M.D has received a total of $5,365 in payments from pharmaceutical and medical device companies, with $897.37 received in 2024. These payments were reported across 281 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,203).
As a Medicare-enrolled provider, Yasser has provided services to 1,669 Medicare beneficiaries, totaling 2,415 services with total Medicare billing of $254,843. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Katy, TX
- Active Since 09/28/2006
- Last Updated 06/11/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1558453522
Products in Payments
- NUPLAZID (Drug) $393.18
- Briviact (Drug) $322.68
- APTIOM (Drug) $296.51
- NURTEC ODT (Drug) $296.36
- Gamunex-C (Biological) $230.39
- RYTARY (Drug) $168.70
- UBRELVY (Drug) $168.60
- VNS Therapy (Device) $166.57
- KESIMPTA (Drug) $156.37
- TECFIDERA (Drug) $152.63
- TROKENDI XR (Drug) $145.52
- INGREZZA (Drug) $143.25
- EMGALITY (Drug) $141.61
- AJOVY (Biological) $136.87
- REXULTI (Drug) $136.38
- QULIPTA (Drug) $134.11
- COPAXONE (Drug) $121.41
- Neupro (Drug) $114.32
- Aimovig (Biological) $95.42
- AIMOVIG (Biological) $90.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Katy
Dr. Jose Diaz, M.d, M.D
Neurology — Payments: $105,577
Neurology $105,577
Dr. Ankit Patel, M.d, M.D
Neurology — Payments: $21,121
Neurology $21,121
Sevak Ohanian, Md, MD
Neurology — Payments: $20,220
Neurology $20,220
Shima Bozorgui, Md, Mph, MD, MPH
Neurology — Payments: $155.34
Neurology $155.34
Ibrahim Noorbhai
Neurology — Payments: $40.16
Neurology $40.16
Hannah Sutherland, Pt, Dpt, PT, DPT
Neurology
Neurology